Colistin is a peptide antibiotic of the polymyxin group, the antibacterial activity of which extends mainly to gram-negative microflora. It is synthesized by the aerobic spore-forming bacillus Bacillus polymyxa and has a pronounced bactericidal effect against most aerobic gram-negative microorganisms, including Escherichia coli, Salmonella spp., Pasteurella spp., Bordetella spp., Klebsiella spp., Pseudomonas aeruginosa.
The mechanism of bactericidal action of colistin is to disrupt the permeability of the cytoplasmic membrane, which leads to its destruction and subsequent lysis of the bacterial cell. Bacterial resistance to colistin develops very slowly.
With oral administration of the veterinary product, colistin sulfate is practically not absorbed in the gastrointestinal tract, is not affected by digestive enzymes and does not accumulate in tissues, which creates conditions for obtaining a high antibacterial concentration of colistin in the intestinal lumen and allows you to obtain excellent results in the treatment of intestinal diseases caused by gram-negative bacteria.
Colistin is excreted mainly in feces, mainly in an unchanged form.